Search clinical trials for: Hormone-receptor-positive Breast Cancer

Total 89207 results

AmpliMed Corporation

Completed

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

Neoplasm Metastasis

United States
Fujirebio Diagnostics, Inc.

Completed

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

Bladder Cancer

United States
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Non-Small Cell Lung Cancer

Belgium
AZ-VUB
Sanofi

Unknown

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Non-Small-Cell Lung Carcinoma

Belgium
Gachon University Gil Medical Center

Completed

Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain

Advanced Solid Cancers
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and...

Terminated

Study of Velcade and Thalidomide in Patients With Myelodysplasia

Myelodysplastic Syndrome

United States
Gachon University Gil Medical Center

Completed

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Advanced Non-Small Cell Lung Cancer

Korea, Republic of
Gachon University Gil Medical Center

Unknown

Topotecan for Irinotecan-Refractory SCLC

Lung Cancer | Refractory to Chemotherapy

Korea, Republic of
Gachon University Gil Medical Center

Unknown

Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC

Non-Small Cell Lung Cancer

Korea, Republic of
University of North Carolina
RTI International

Completed

Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial

Prostatic Neoplasms

United States
Peking University People's Hospital
Peking University; Sanofi

Unknown

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

Colorectal Cancer | Resectable Liver Metastasis

China
Eisai Inc.
National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals

Completed

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Lymphoma, T-Cell, Cutaneous

United States
Eisai Inc.

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary Syndrome

Germany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
National Cancer Institute (NCI)

Completed

Study of Scaling Disorders and Other Inherited Skin Diseases

Genetic Skin Disease | Lamellar Ichthyosis | Keratosis Follicularis

United States
National Cancer Institute (NCI)

Completed

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

Skin Diseases | Virus Diseases | Healthy | Retinal Degeneration | Muscular Dystrophy

United States
Eisai Inc.

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary Syndrome

Germany, Canada, Australia, United Kingdom, Austria, Russian Federation, United States, Poland, Switzerland
Eisai Inc.

Completed

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

Kidney Neoplasms | Carcinoma, Renal Cell | Adenocarcinoma, Renal Cell

United States, France
National Cancer Institute (NCI)

Completed

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

Neoplasms | Immunologic Deficiency Syndromes

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

Neuroblastoma | Nephroblastoma

United States
National Cancer Institute (NCI)

Completed

Anidulafungin Versus Fluconazole in the Treatment of Candidemia

Candidiasis | Candida

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

Sarcoma | Neuroepithelioma | Osteosarcoma | Neuroectodermal Tumor, Primitive | Sarcoma, Ewing's

United States
National Institute of Dental and Craniofacial Research...

Completed

Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells

Sjogren's Syndrome | Graft vs Host Disease

United States
National Cancer Institute (NCI)

Completed

Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor

HIV Infection

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

Adrenal Cortical Carcinoma

United States
National Cancer Institute (NCI)

Completed

A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma

Sarcoma

United States
National Cancer Institute (NCI)

Completed

A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine

Acquired Immunodeficiency Syndrome | AIDS-Related Complex

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis

Stomach Neoplasms | Peritoneal Neoplasms

United States
National Cancer Institute (NCI)

Completed

New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma

Neuroblastoma | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Assessment of Attentional Functioning in Children With HIV-1 Infection

HIV Infections | Paralysis | Attention Deficit Disorder With Hyperactivity

United States
National Institute of Dental and Craniofacial Research...

Completed

Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation

Radiation Injuries | Xerostomia

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations

HIV Infections

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Drug Interactions Among Anti-HIV Agents

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples

Urologic Neoplasms | Neoplastic Syndromes, Hereditary

United States
National Cancer Institute (NCI)

Completed

A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning

Neoplasm

United States
National Cancer Institute (NCI)

Completed

The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies

Lymphoma | Healthy | Chronic Myeloid Leukemia | Hematologic Neoplasm

United States
National Cancer Institute (NCI)

Completed

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Acquired Immunodeficiency Syndrome | Smoking | Alcoholism | HIV Infection | Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Kidney Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Neoplasm Metastasis | Liver Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

United States
National Cancer Institute (NCI)

Completed

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

HIV Infection

United States
National Cancer Institute (NCI)

Completed

The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection

HIV Infections | Speech Disorders | Candidiasis, Oral | Eating Disorders

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States
National Cancer Institute (NCI)

Completed

The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities

Sarcoma

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction

Kidney Diseases

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy

Neoplasms

United States

3

Subscribe